These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22007072)

  • 1. ACP Journal Club. Proton-pump inhibitors were associated with reduced effectiveness of alendronate for preventing hip fractures.
    Ito K
    Ann Intern Med; 2011 Oct; 155(8):JC4-13. PubMed ID: 22007072
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitor use and the antifracture efficacy of alendronate.
    Abrahamsen B; Eiken P; Eastell R
    Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACP Journal Club: review: proton-pump inhibitors are associated with increased risk for Clostridium difficile infection.
    Koretz RL
    Ann Intern Med; 2012 Aug; 157(4):JC2-13. PubMed ID: 22910967
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI.
    Aronow HD
    Ann Intern Med; 2010 Dec; 153(12):JC6-13. PubMed ID: 21173402
    [No Abstract]   [Full Text] [Related]  

  • 5. Opportunities to decrease inappropriate uses of proton pump inhibitors: Comment on "Proton pump inhibitor use and the antifracture efficacy of alendronate".
    Katz MH
    Arch Intern Med; 2011 Jun; 171(11):1004-5. PubMed ID: 21321289
    [No Abstract]   [Full Text] [Related]  

  • 6. Responses to AFP journal club on hip fracture and PPI use.
    Millard PS
    Am Fam Physician; 2009 Jan; 79(2):83; author reply 83-4. PubMed ID: 19178057
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club: high-dose and non-high-dose proton pump inhibitors after endoscopic treatment do not differ for bleeding peptic ulcers.
    Yen ZS
    Ann Intern Med; 2010 Sep; 153(6):JC3-11. PubMed ID: 20855788
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses to AFP journal club on hip fracture and PPI use.
    Steichen O
    Am Fam Physician; 2009 Jan; 79(2):83; author reply 83-4. PubMed ID: 19180747
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI.
    Granger CB
    Ann Intern Med; 2009 Aug; 151(4):JC2-13. PubMed ID: 19687487
    [No Abstract]   [Full Text] [Related]  

  • 10. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women.
    Hsiao FY; Huang WF; Chen YM; Wen YW; Kao YH; Chen LK; Tsai YW
    Clin Ther; 2011 Nov; 33(11):1659-67. PubMed ID: 22018450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of alendronate preventing hip fracture risk of postmenopausal women].
    Yuan T; Li XL; Zhang CQ; Shi HP; Zeng BF
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1620-2. PubMed ID: 19957509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACP Journal Club. Review: Oral vitamin D prevents nonvertebral and hip fractures in a dose-dependent manner in patients 65 years of age.
    Denman M
    Ann Intern Med; 2009 Aug; 151(4):JC2-8. PubMed ID: 19687482
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: Some drugs are effective for preventing migraine headache; limited evidence exists on the relative effectiveness of drugs.
    Roxas R
    Ann Intern Med; 2010 Nov; 153(10):JC5-4. PubMed ID: 21079211
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
    J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
    Bona R
    Ann Intern Med; 2012 Aug; 157(4):JC2-5. PubMed ID: 22910959
    [No Abstract]   [Full Text] [Related]  

  • 18. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.
    Bauer DC; Black DM; Garnero P; Hochberg M; Ott S; Orloff J; Thompson DE; Ewing SK; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1250-8. PubMed ID: 15231011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacement.
    Douketis J
    Ann Intern Med; 2011 May; 154(10):JC5-07, JC5-06. PubMed ID: 21576525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.